2025 first_quarter Filing

Issues related to tariffs.

Monitored issues related to pharmaceutical prices. Issues related to dialysis. Issues regarding the pharmaceutical supply chain. Monitored issues concerning drug shortages. Issues concerning the reauthorization of Pandemic and All-Hazards Preparedness and Response Act (PAHPA). Monitored AI issues. Monitored cybersecurity issues. Issues concerning Hurricane Helene.
H.R. 1968 (P.L. 119-4), Full-Year Continuing Appropriations and Extensions Act, 2025.

Issues related to ESRD, including increasing home dialysis. Implementation of drug pricing provisions related to H.R. 5376 (P.L. 117-169), The Inflation Reduction Act. Monitored issues related to safe mobility. Issues related to reimbursement for breakthrough devices. Issues related to drug shortages. Issues related to extension of the hospital at home program.

Monitored H.R. 1990, the American Innovation and R&D Competitiveness Act, and issues related to the R&D tax credit. Monitor issues related to the expiration of the 2017 Tax Cut & Jobs Act.